Navigation Links
HIV Drug a Double-Edged Sword for Infants
Date:1/18/2009

Nevirapine protects during breast-feeding, but resistant disease can develop in first year, study shows,,,,

SUNDAY, Jan. 18 (HealthDay News) -- The antiretroviral drug nevirapine may help prevent babies of HIV-positive mothers from getting the virus through breast-feeding, but it also greatly increases the odds of developing drug-resistant HIV if they are infected during the first year of life, a new study finds.

Still, the researchers consider the six-week course of the drug the best alternative available.

Given the higher chance of a baby on nevirapine acquiring treatment-resistant HIV, the authors call for the infants to also receive protease inhibitors (PIs), which can combat nevirapine-resistant HIV strains.

"Until other interventions become available, the extended nevirapine regimen remains a reasonable way to prevent infections through breast-feeding," senior investigator Dr. Deborah Persaud, a pediatric HIV expert at John Hopkins Children's Center, said in a news release issued by the school.

The study, published in the Jan. 1 issue of the Public Library of Science One, noted the treatment is best for HIV-positive mothers in developing countries where bottle feeding is not an alternative because of cost, safety or availability.

HIV infection is estimated to occur in one out of 10 breast-fed infants, most of the time happening in the first 14 weeks of life, according to estimates by the World Health Organization (WHO), which recommends breast-feeding for at least six months despite the known risk of HIV transmission.

Two reports published in 2008 found that a six-week treatment of nevirapine cut the risk of HIV infection from breast-feeding nearly in half, while a 14-week regimen cut it by 66 percent.

More information

The U.S. National Institute of Allergy and Infectious Disease has more about HIV infection in women.



-- Kevin McKeever



SOURCE: Johns Hopkins Children's Center, news release, Jan. 5, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Anemia treatment may be a double-edged sword
2. Cellular senescence a double-edged sword
3. Nicotine in breast milk disrupts infants sleep patterns
4. Shaking may cause brain damage and serious long-term effects to infants
5. Maternal depression and controlling behavior associated with increased stress response in infants
6. Repeat steroids to premature infants linked to cerebral palsy
7. Babies raised in bilingual homes learn new words differently than infants learning one language
8. Research shows how genetic mutation causes epilepsy in infants
9. Combination vaccines okay for infants, study shows
10. $4 million nursing grant focuses on at-risk premature infants
11. McNeil Consumer Healthcare is Voluntarily Withdrawing Infants Cough and Cold Products:
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug a Double-Edged Sword for Infants
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance ... change designed to further positively impact the health and wellness of our community ... considered it our duty to seriously consider releasing our assets beyond our 5% ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 ... manufacturers distinguish between corrective action (CA) and preventive action (PA)? , The methods ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... executives and focusing on all facets of clinical trial planning and management. Pharmica ... patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were able ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... financial planning assistance to families and business owners in and around the Hampton ... drive to help prevent all forms of domestic violence. , There are multiple ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... planning services to families and entrepreneurs in the Birmingham area, is announcing an ... who needs assistance with her medically challenged son, Anius. , Anius is medically ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... -- Absorption Systems, a global leader in nonclinical testing ... announce that its Chief Operating Officer, Sid Bhoopathy ... the 2017 Executive Management Award. The award is sponsored ... for their creative management vision, leadership philosophy, innovative strategy ... is on March 8, 2017 at the Ballroom at ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today ... 2016. Net income attributable to DaVita Inc. ... $158 million, or $0.80 per share and $880 million, or ... attributable to DaVita Inc. for the quarter and year ended ... $192 million, or $0.98 per share, and $789 million, or ...
(Date:2/16/2017)... Feb. 16, 2017 The Lockwood Group (Lockwood), a ... Place to Work in Connecticut list ... third year in a row that Lockwood has been in ... earn the number-two spot in 2017. The award recognizes companies ... The winners were determined through a survey conducted by The ...
Breaking Medicine Technology: